Yang QuanJun

15PUBLICATIONS
29CO-AUTHORS
Tumour immunologyBiomolecular modelling and designMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 11, 2026
Advances and challenges in immunotherapy for intrahepatic cholangiocarcinoma based on the tumour immune microenvironment.

|Aug 24, 2026
Identification of a candidate PRODH allosteric inhibitor MBTP-15324: modulation of proline metabolite profiles and ECM-associated gene-expression changes in lung cancer cells.

|Jul 25, 2026
Targeting the CD47-SIRPĪ± phagocytic checkpoint in cancer: Biology, translational opportunities, and next-generation therapeutic strategies.

|May 07, 2026
Fisetin Promotes Autophagy in Osteosarcoma by Activating the ROS/FOXO3 Axis via Oxidative Stress.

|Jan 19, 2026
A charge-reversal prodrug activated by tumor-acidity for selective cancer chemotherapy.

Bing Liu, Guanchun Wang, Quanjun Yang

|Sep 08, 2025
Arginine Metabolism in Cancer Biology and Immunotherapy.

DingYuan Bai, YuXuan Zhou, LingJie Jing

Pageof 3

Frequent Collaborators

5 joint publications

Cheng Guo

2 joint publications

Yonglong Han

1 joint publications

Paul Renauer

1 joint publications

Jonathan J Park